STING1 and neoplasm: Despite this common suppression, the ability to target and restore STING signaling in tumor cells using epigenetic modulators35,37 provides a rationale to explore whether epigenetic reprogramming of tumor cell-intrinsic STING activity can improve the therapeutic efficacy of STING agonists.